JAK Inhibitors for ET and PV: What Have We Learned So Far - 100004

Spotlight
Video

JAK Inhibitors for ET and PV: What Have We Learned So Far

imedex has 1221 videos Subscribe Here

Loading........
Description: In this presentation from the 2016 US Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes, held August 26-27 in Alexandria, VA, Dr. Ellen Ritchie discusses what we have learned thus far regarding the use of JAK inhibitors for the treatment of essential thrombocythemia (ET) and polycythemia vera (PV).

Earn accreditation for a related activity at the following location:
http://elc.imedex.com/ELC/A...

© 2016 Imedex, LLC.
Shared By : imedex
Posted on : 09/28/16
Added : 2 years ago